IN2015MN00027A - - Google Patents
Download PDFInfo
- Publication number
- IN2015MN00027A IN2015MN00027A IN27MUN2015A IN2015MN00027A IN 2015MN00027 A IN2015MN00027 A IN 2015MN00027A IN 27MUN2015 A IN27MUN2015 A IN 27MUN2015A IN 2015MN00027 A IN2015MN00027 A IN 2015MN00027A
- Authority
- IN
- India
- Prior art keywords
- polypeptides
- fniii
- making
- methods
- pharmaceutical compositions
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 102000016359 Fibronectins Human genes 0.000 abstract 1
- 108010067306 Fibronectins Proteins 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Prostheses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261656671P | 2012-06-07 | 2012-06-07 | |
| PCT/US2013/044699 WO2013185027A2 (en) | 2012-06-07 | 2013-06-07 | Modified fibronectin fragments or variants and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2015MN00027A true IN2015MN00027A (es) | 2015-10-16 |
Family
ID=49712865
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN27MUN2015 IN2015MN00027A (es) | 2012-06-07 | 2013-06-07 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9969791B2 (es) |
| EP (1) | EP2859113A4 (es) |
| JP (1) | JP6297543B2 (es) |
| KR (1) | KR20150041619A (es) |
| CN (1) | CN104968796A (es) |
| AU (1) | AU2013271445B2 (es) |
| BR (1) | BR112014030716A2 (es) |
| CA (1) | CA2876135A1 (es) |
| IL (1) | IL236098A0 (es) |
| IN (1) | IN2015MN00027A (es) |
| MX (1) | MX2014015028A (es) |
| SG (1) | SG11201408163VA (es) |
| TW (1) | TWI580692B (es) |
| WO (1) | WO2013185027A2 (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9969791B2 (en) * | 2012-06-07 | 2018-05-15 | National Cheng Kung University | Modified fibronectin fragments or variants and uses thereof |
| US10533044B2 (en) | 2014-01-06 | 2020-01-14 | The General Hospital Corporation | Integrin Antagonists |
| DK3313869T3 (da) | 2015-06-26 | 2021-05-10 | Spiber Tech Ab | Cyklisk rgd-cellebindende motiv og anvendelser deraf |
| EP3365353B1 (en) | 2015-10-23 | 2023-11-22 | Universiteit Twente | Integrin binding peptides and uses thereof |
| WO2019165017A1 (en) * | 2018-02-23 | 2019-08-29 | The University Of Chicago | Methods and composition involving thermophilic fibronectin type iii (fn3) monobodies |
| US11685717B2 (en) | 2018-08-08 | 2023-06-27 | The General Hospital Corporation | Polypeptide integrin antagonists |
| CN111285932B (zh) * | 2018-12-10 | 2023-07-11 | 武汉禾元生物科技股份有限公司 | 一种从基因工程水稻种子中分离纯化重组人纤维连接蛋白的方法 |
| CN113092772A (zh) * | 2019-12-23 | 2021-07-09 | 首都医科大学附属北京世纪坛医院 | 尿液黏连蛋白亚组sa-2及其多肽片段在过敏性疾病中的应用 |
| CN112941081B (zh) * | 2021-04-16 | 2023-04-21 | 广州启点生物科技有限公司 | 一种纤连蛋白突变体及其制备方法与应用 |
| US11723955B1 (en) | 2022-05-13 | 2023-08-15 | Allgenesis Biotherapeutics Inc. | VEGFR fusion protein pharmaceutical composition |
| CN117298257A (zh) * | 2023-07-14 | 2023-12-29 | 杭州恩和生物科技有限公司 | 人纤连蛋白或其功能片段的用途、筛选方法和试剂盒 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4554101A (en) | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
| US5753230A (en) * | 1994-03-18 | 1998-05-19 | The Scripps Research Institute | Methods and compositions useful for inhibition of angiogenesis |
| US20050118661A1 (en) * | 2002-01-21 | 2005-06-02 | Helen Mardon | Fibronectin variants and screening methods |
| CN101951938B (zh) * | 2008-01-18 | 2016-04-13 | 伯纳姆医学研究所 | 内化rgd肽相关的方法和组合物 |
| CA2821715A1 (en) * | 2010-12-14 | 2012-06-21 | University Of Rochester | Chimeric fibronectin matrix mimetics and uses thereof |
| US9969791B2 (en) * | 2012-06-07 | 2018-05-15 | National Cheng Kung University | Modified fibronectin fragments or variants and uses thereof |
-
2013
- 2013-06-07 US US14/406,215 patent/US9969791B2/en active Active
- 2013-06-07 JP JP2015516240A patent/JP6297543B2/ja active Active
- 2013-06-07 CA CA2876135A patent/CA2876135A1/en not_active Abandoned
- 2013-06-07 EP EP13800217.5A patent/EP2859113A4/en not_active Withdrawn
- 2013-06-07 TW TW102120488A patent/TWI580692B/zh active
- 2013-06-07 SG SG11201408163VA patent/SG11201408163VA/en unknown
- 2013-06-07 BR BR112014030716A patent/BR112014030716A2/pt not_active Application Discontinuation
- 2013-06-07 IN IN27MUN2015 patent/IN2015MN00027A/en unknown
- 2013-06-07 MX MX2014015028A patent/MX2014015028A/es unknown
- 2013-06-07 AU AU2013271445A patent/AU2013271445B2/en not_active Ceased
- 2013-06-07 WO PCT/US2013/044699 patent/WO2013185027A2/en active Application Filing
- 2013-06-07 KR KR20157000345A patent/KR20150041619A/ko not_active Application Discontinuation
- 2013-06-07 CN CN201380030284.2A patent/CN104968796A/zh active Pending
-
2014
- 2014-12-07 IL IL236098A patent/IL236098A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TWI580692B (zh) | 2017-05-01 |
| SG11201408163VA (en) | 2015-01-29 |
| JP6297543B2 (ja) | 2018-03-20 |
| BR112014030716A2 (pt) | 2018-06-26 |
| TW201412770A (zh) | 2014-04-01 |
| WO2013185027A2 (en) | 2013-12-12 |
| EP2859113A2 (en) | 2015-04-15 |
| AU2013271445A1 (en) | 2015-01-22 |
| CA2876135A1 (en) | 2013-12-12 |
| JP2015521588A (ja) | 2015-07-30 |
| AU2013271445B2 (en) | 2016-12-15 |
| KR20150041619A (ko) | 2015-04-16 |
| EP2859113A4 (en) | 2016-04-13 |
| IL236098A0 (en) | 2015-01-29 |
| US9969791B2 (en) | 2018-05-15 |
| MX2014015028A (es) | 2015-08-06 |
| CN104968796A (zh) | 2015-10-07 |
| US20150218251A1 (en) | 2015-08-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2015MN00027A (es) | ||
| PH12019500627A1 (en) | Affinity-oligonucleotide conjugates and uses thereof | |
| MX2013015311A (es) | Polipeptidos de enlace de pcsk9 y metodos de uso. | |
| PH12017502180A1 (en) | Tau-binding antibodies | |
| PH12014502132A1 (en) | Anti-lgr5 antibodies and immunoconjugates | |
| SG10201803042PA (en) | Anti-tim-3 antibodies | |
| MY178142A (en) | Anti-phf-tau antibodies and their uses | |
| IN2015DN00127A (es) | ||
| MX2019008211A (es) | Estructuras fibrosas que comprenden particulas y metodos para fabricarlas. | |
| MX2013011479A (es) | Anticuerpos anti-fgfr4 y metodos de uso. | |
| MX2014002053A (es) | Anticuerpos anti -mcsp y metodos de uso. | |
| PH12015501059A1 (en) | Anti-hemagglutinin antibodies and methods of use | |
| PH12015501835A1 (en) | Methods for the synthesis of sphingomyelins and dihydrosphingomyelins | |
| PH12014501605A1 (en) | Anti-lrp5 antibodies and methods of use | |
| MX2014004022A (es) | Anticuerpos anti-htra1 y metodos de uso. | |
| PH12017502207A1 (en) | Tau-binding antibodies | |
| MX340555B (es) | Anticuerpos contra il-18r1 y usos de los mismos. | |
| MX354303B (es) | Anticuerpos de anti-biotina y metodos de uso. | |
| JO3755B1 (ar) | تركيبات تستوستيرون | |
| MX2013011853A (es) | Polipeptidos antibacterianos quimericos. | |
| MX336323B (es) | Anticuerpos de anti-poliubiquitina y metodos de uso. | |
| IN2013MU00848A (es) | ||
| EP4023243A3 (en) | Compositions and methods for treating celiac sprue disease | |
| IN2014CN00312A (es) | ||
| MY165088A (en) | Pharmaceutical compositions comprising alisporivir |